1. Home
  2. IMMP vs OPOF Comparison

IMMP vs OPOF Comparison

Compare IMMP & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • OPOF
  • Stock Information
  • Founded
  • IMMP 1987
  • OPOF 1922
  • Country
  • IMMP Australia
  • OPOF United States
  • Employees
  • IMMP N/A
  • OPOF N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • OPOF Major Banks
  • Sector
  • IMMP Health Care
  • OPOF Finance
  • Exchange
  • IMMP Nasdaq
  • OPOF Nasdaq
  • Market Cap
  • IMMP 251.8M
  • OPOF 205.7M
  • IPO Year
  • IMMP N/A
  • OPOF N/A
  • Fundamental
  • Price
  • IMMP $1.76
  • OPOF $41.72
  • Analyst Decision
  • IMMP Buy
  • OPOF
  • Analyst Count
  • IMMP 1
  • OPOF 0
  • Target Price
  • IMMP $7.00
  • OPOF N/A
  • AVG Volume (30 Days)
  • IMMP 79.3K
  • OPOF 19.8K
  • Earning Date
  • IMMP 10-21-2025
  • OPOF 07-30-2025
  • Dividend Yield
  • IMMP N/A
  • OPOF 1.34%
  • EPS Growth
  • IMMP N/A
  • OPOF 21.17
  • EPS
  • IMMP N/A
  • OPOF 1.70
  • Revenue
  • IMMP $3,019,249.00
  • OPOF $61,004,000.00
  • Revenue This Year
  • IMMP $50.37
  • OPOF N/A
  • Revenue Next Year
  • IMMP N/A
  • OPOF N/A
  • P/E Ratio
  • IMMP N/A
  • OPOF $24.50
  • Revenue Growth
  • IMMP 24.11
  • OPOF 4.45
  • 52 Week Low
  • IMMP $1.32
  • OPOF $17.02
  • 52 Week High
  • IMMP $2.72
  • OPOF $42.13
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 52.82
  • OPOF 59.36
  • Support Level
  • IMMP $1.63
  • OPOF $40.45
  • Resistance Level
  • IMMP $1.85
  • OPOF $42.13
  • Average True Range (ATR)
  • IMMP 0.07
  • OPOF 0.63
  • MACD
  • IMMP -0.01
  • OPOF 0.02
  • Stochastic Oscillator
  • IMMP 52.08
  • OPOF 82.48

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About OPOF Old Point Financial Corporation

Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.

Share on Social Networks: